HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 912211Generated: November 2, 2026
Potassium Phosphate, Tribasic → HCID 67385929, compound
https://huagongshe.com/reaction/912211
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Potassium Phosphate, Tribasic | HCID 62657 | — |
| Reactant | 1-Ethylpiperazine | HCID 79196 | — |
| Reactant | 2-Dicyclohexylphosphino-2',6'-dimethoxybiphenyl | HCID 11269872 | — |
| Reactant | HCID 59244836 | HCID 59244836 | — |
| Catalyst | Bis(dibenzylideneacetone)palladium | HCID 9811564 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 67385929 | HCID 67385929 | — |
Reaction Steps
4-{2-[Bis-(4-methoxy-benzyl)-amino]-pyrimidin-5-yl}-2-morpholin-4-yl-5,6-dihydro-pyrrolo[2,3-d]pyrimidine-7-carboxylic acid (3-iodo-phenyl)-amide (48 mg) obtained in Step A, 1-ethyl-piperazine (77.5 μl), tris(dibenzylideneacetone)dipalladium (5.5 mg), S-Phos (5.0 mg) and potassium phosphate (26.0 mg) were stirred in DMF (5 ml) at 100° C. for 3 hours. To this, water was added, to filter the solid, which was dissolved in dichloromethane, followed by drying over sodium sulfate. After the sodium sulfate was filtered off, the solvent was distilled off under reduced pressure, followed by purification by silica gel column chromatography (dichloromethane/methanol=100/1 to 20/1), to obtain 4-{2-[bis-(4-methoxy-benzyl)-amino]-pyrimidin-5-yl}-2-morpholin-4-yl-5,6-dihydro-pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-(4-ethyl-piperazin-1-yl)-phenyl]-amide as a crude product. To this compound (23.1 mg), N-Acetylcysteine (10 mg) was added, followed by refluxing in TFA (1 ml) for 6 hours. TFA was distilled off, followed by purification by silica gel column chromatography (dichloromethane/2M-ammonia methanol=1/0 to 20/1), and further the resulting solid was washed with saturated sodium hydrogencarbonate aqueous solution (3 ml), water (3 ml) and acetonitrile (3 ml), to obtain the desired compound (D-81) as a yellow solid (12.5 mg, 79%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08022205B2 |
|---|
| Source dataset | uspto-grants-2011_09 |
|---|
| ORD ID | ord-a8e8dee622d34421bb84ca09c5cfc094 |
|---|
| Source note | uspto-grants-2011_09 |
|---|